The IVD product portfolio includes devices that assist in clinical chemistry & immunoassays, urinalysis, point-of-care testing, and patient self-testing devices.
This report contains market size and forecasts of Lab Automation for In-vitro Diagnostics in global, including the following market information:
Global Lab Automation for In-vitro Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Lab Automation for In-vitro Diagnostics Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Lab Automation for In-vitro Diagnostics companies in 2021 (%)
The global Lab Automation for In-vitro Diagnostics market was valued at 5274 million in 2021 and is projected to reach US$ 8535.7 million by 2028, at a CAGR of 7.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Automated Plate Handler Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lab Automation for In-vitro Diagnostics include Cognex Corporation, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies, Inc, Abbott, PerkinElmer, Inc, Tecan Group Ltd and BD and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lab Automation for In-vitro Diagnostics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lab Automation for In-vitro Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Lab Automation for In-vitro Diagnostics Market Segment Percentages, by Type, 2021 (%)
Automated Plate Handler
Automated Liquid Handler
Robotic Arm
Others
Global Lab Automation for In-vitro Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Lab Automation for In-vitro Diagnostics Market Segment Percentages, by Application, 2021 (%)
Academic
Laboratory
Others
Global Lab Automation for In-vitro Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Lab Automation for In-vitro Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lab Automation for In-vitro Diagnostics revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Lab Automation for In-vitro Diagnostics revenues share in global market, 2021 (%)
Key companies Lab Automation for In-vitro Diagnostics sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Lab Automation for In-vitro Diagnostics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cognex Corporation
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc
Danaher Corporation
Agilent Technologies, Inc
Abbott
PerkinElmer, Inc
Tecan Group Ltd
BD
Siemens